Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):275-277. doi: 10.1016/j.htct.2021.04.007. Epub 2021 Jun 16.
No abstract available

Publication types

  • Case Reports